Search

You searched for "regenerative"

1504 results found

MacuMira and Keeler announce strategic partnership to expand dry AMD therapy

11 December 2025 | Contracts & Distributors, Research & Development

Keeler, a global leader in ophthalmic innovation with more than a century of heritage, and MacuMira Medical Devices Inc, a pioneering Canadian company, has announced a strategic partnership. Under the agreement, Keeler will manufacture the MacuMira device and lead its...

Everyday diabetes medicine could treat common cause of blindness

16 February 2026 | research, pharma

Doctors have found that metformin, an everyday medicine for diabetes, is associated with less progression of age-related macular degeneration (AMD), the commonest cause of blindness in western countries. People with diabetes over the age of 55 years taking metformin were...

Management of a giant pigment epithelium detachment with transition from half- to full-dose aflibercept

2 March 2026 | Muiz Musadiq, Sindhu Saraswathy Bhaskaran | EYE - Imaging, EYE - Vitreo-Retinal

This case report describes the management of a giant pigment epithelial detachment (PED) in neovascular age-related macular degeneration (nAMD) using half-dose aflibercept. An 80-year-old woman presented with a huge PED (maximum height 1338µm) and multiple risk factors for retinal pigment...

Bus drivers swap with blind passengers

18 May 2026 | patient stories

Drivers at the Xplore Dundee depot took part in a hands-on session today [Wednesday 6 May] to better understand the experiences of blind and partially sighted passengers. The company held a ‘Swap With Me’ event in which volunteers from national...

Global health and conflict: the unseen consequences

27 October 2021 | Priyancaa Jeyabaladevan | EYE - Orbit, EYE - General

Global eye health inequalities stem from poor access to affordable care, causing preventative vision impairment and blindness. In 2020, a study showed that 510 million people, the majority being in low-income and middle-income countries, had uncorrected near vision impairment simply...

Artificial intelligence and oculomics: Improving global health

2 June 2025 | Charles Cleland, Elliott Taylor | EYE - Imaging

The application of artificial intelligence (AI), and in particular deep learning, to high-resolution ocular imaging has led to many new discoveries, enabling the prediction of multiple different systemic diseases from ocular biomarkers. This emerging field is known as ‘oculomics’ [1]....

Pathway innovations to address cataract services post-COVID-19

1 June 2022 | Sam Evans, Tine Jacobs, Hari Kaneshayogan, Leo Feinberg, Conor Ramsden | EYE - Cataract, EYE - Refractive

Background The demand for cataract services prior to the COVID-19 pandemic was already recognised to be high and growing - in the face of an ageing population and reduced surgical thresholds. When added to the growth in demand for ophthalmic...

The role of spectral-domain OCT RNFL in revealing a pituitary adenoma with atypical visual fields

3 April 2026 | Jibran Riaz, Manzar Saeed | EYE - Imaging, EYE - Neuro-ophthalmology

Pituitary adenomas classically cause bitemporal hemianopia by compressing the optic chiasm. However, in some cases, the pattern of visual field loss may be atypical and mimic homonymous hemianopia, depending on the direction and extent of tumour expansion. Spectral-domain optical coherence...

Does vitrectomy increase the risk of glaucoma? A retrospective review from a UK hospital

5 April 2022 | Aiman Jamal, Helen Burn, Asifa Shaikh | EYE - Glaucoma, EYE - Vitreo-Retinal, EYE - General

The authors investigate what proportion of patients undergoing pars plana vitrectomy subsequently developed ocular hypertension or a diagnosis of glaucoma. A systematic review carried out in 2017 including seven studies found that there is evidence that pars plana vitrectomy (PPV)...

«
37
38
39
40
41
42 (current)
43
44
45
46
47
»